Search results
Results from the WOW.Com Content Network
Bromocriptine, originally marketed as Parlodel and subsequently under many brand names, [1] is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes.
[citation needed] Although cabergoline is commonly described principally as a D 2 receptor agonist, it also possesses significant affinity for the dopamine D 3, and D 4, serotonin 5-HT 1A, 5-HT 2A, 5-HT 2B, and 5-HT 2C, and α 2-adrenergic receptors, as well as moderate/low affinity for the dopamine D 1, serotonin 5-HT 7, and α 1-adrenergic ...
[1] [53] [54] A systematic review and meta-analysis has shown that cabergoline and quinagolide are more effective in the treatment of hyperprolactinemia compared to bromocriptine, [55] this is because evidence had suggested fewer side effects, rapid titration and offers better dosing interval in medication like quinagolide compared to ...
For premium support please call: 800-290-4726 more ways to reach us
Men without prostate cancer typically have PSA levels of under 4 nanograms per milliliter (ng/mL), according to the American Cancer Society. PSA levels between 4 and 10 suggest you could have ...
As of 2011, among those in psychiatric hospitals on antipsychotics about 15 per 100,000 are affected per year (0.015%). [1] In the second half of the 20th century rates were over 100 times higher at about 2% (2,000 per 100,000). [1] Males appear to be more often affected than females. [1] The condition was first described in 1956. [1]
Diethylstilbestrol dipropionate (DESDP) (brand names Agostilben, Biokeral, Clinestrol, Cyclen, Estilbin, Estril, Neobenzoestrol, Orestol, Oroestrol, Ostregenin, Prostilbene, Stilbestriol DP, Stilboestrolum Dipropionicum, Stilboestrol, Synestrin, Willestrol, others), or diethylstilbestrol dipropanoate, also known as stilboestrol dipropionate (BANM Tooltip British Approved Name), is a synthetic ...
If spiperone was added as soon as 1 min after I, the antagonist was unable to block the complete expression of the I inhibition. Evidently, I is a functionally irreversible dopamine agonist for at least the 4 h of these studies." source: European Journal of Pharmacology 1984, 99(1), p.85 Nagelfar 19:03, 20 October 2008 (UTC)